Anna Dahlén

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis
    A Dahlen
    Department of Clinical Genetics, University Hospital, SE 221 85, Lund, Sweden
    Cancer Genet Cytogenet 131:19-24. 2001
  2. ncbi Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Int J Cancer 103:616-23. 2003
  3. ncbi Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Mod Pathol 16:1132-40. 2003
  4. pmc Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Am J Pathol 164:1645-53. 2004
  5. ncbi Molecular genetic characterization of the genomic ACTB-GLI fusion in pericytoma with t(7;12)
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, SE 221 85 Lund, Sweden
    Biochem Biophys Res Commun 325:1318-23. 2004
  6. pmc Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy
    Jens Engleson
    Department of Oncology, Lund University Hospital, SE 221 85, Lund, Sweden
    BMC Cancer 6:69. 2006
  7. ncbi Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera
    Ioannis Panagopoulos
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Genes Chromosomes Cancer 46:181-91. 2007

Detail Information

Publications7

  1. ncbi Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis
    A Dahlen
    Department of Clinical Genetics, University Hospital, SE 221 85, Lund, Sweden
    Cancer Genet Cytogenet 131:19-24. 2001
    ..By hematoxylin-eosin staining of the slides used for FISH analysis it could be shown that the clustered trisomic cells were proliferating synoviocytes within villous extensions of the synovial membrane...
  2. ncbi Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Int J Cancer 103:616-23. 2003
    ..Our findings strongly indicate that deletion of a limited region (approximately 2.5 Mbp) within 13q14, distal to the RB1-locus, is of importance in the development of a subset of lipomatous tumors...
  3. ncbi Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Mod Pathol 16:1132-40. 2003
    ..A truncated or full-length transcript was found in 8 of 13 chondrosarcomas, 4 of which displayed 12q rearrangements. Possibly, cryptic rearrangements were present among the many complex marker chromosomes in the remaining 4 cases...
  4. pmc Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Am J Pathol 164:1645-53. 2004
    ....
  5. ncbi Molecular genetic characterization of the genomic ACTB-GLI fusion in pericytoma with t(7;12)
    Anna Dahlén
    Department of Clinical Genetics, University Hospital, SE 221 85 Lund, Sweden
    Biochem Biophys Res Commun 325:1318-23. 2004
    ..Whereas large repeats or recombinase recognition sequences were not detected, sequences of shared oligonucleotides, possibly important for recombination, were found in the proximity of the respective breakpoints...
  6. pmc Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy
    Jens Engleson
    Department of Oncology, Lund University Hospital, SE 221 85, Lund, Sweden
    BMC Cancer 6:69. 2006
    ..This tumor affects young individuals, shows a rapidly fatal clinical course despite intensive therapy. The t(15;19) results in the fusion oncogene BRD4-NUT. Information concerning treatment of this rare disorder is scarce...
  7. ncbi Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera
    Ioannis Panagopoulos
    Department of Clinical Genetics, University Hospital, Lund, Sweden
    Genes Chromosomes Cancer 46:181-91. 2007
    ..Thus, studies regarding the pathways influenced by wild-type CREB3L2 should provide valuable clues to the pathogenetic significance of the FUS/CREB3L2 chimera in low grade fibromyxoid sarcoma...